PACB
PACB
NASDAQ · Life Sciences Tools & Services

Pacific Biosciences Of Calif

$2.27
-0.28 (-10.98%)
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Buy 9 64%
Hold 4 29%
Sell 1 7%
Price Target
Analyst Price Target +1,966.1% upside
Low Target $34.06
Average Target $46.90
High Target $60.93
Current Price $2.27
Current
$2.27
Target
$46.90
$34.06 $46.90 avg $60.93
Scenario Analysis
Bear Case
$34.06
1,400.4%
Low target
Base Case
$46.90
+1,966.1%
Avg target
Bull Case
$60.93
+2,584.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$3.44
-33.9% from high
52-Week Low
$1.07
+112.1% from low
Target vs 52W High
$46.90
+1,265.4% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 35 86% $369.21 -45.5%
DHR
Danaher Corp
Strong Buy 31 87% $158.11 -30.1%
A
Agilent Technologies Inc
Buy 29 72% $64.69 -62.3%
WAT
Waters Corp
Buy 30 70% $189.60 -58.2%
IQV
Iqvia Holdings Inc
Strong Buy 27 85% $82.96 -68.7%
ILMN
Illumina Inc
Buy 28 57% $169.36 -18.6%
MTD
Mettler-Toledo International
Hold 19 47% $170.43 -89.8%
WST
West Pharmaceutical Services
Strong Buy 22 95% $136.24 -65.3%